Search for: [Abstract = "with inoperable primary tumour with positive results of the pre\-therapeutic scintigraphy with labelled somatostatin analogues. Radioimmunotherapy is an alternative method of treatment of lymphomas resistant to the standard treatment. The aim of the study was to assess the effectiveness of the therapy with 90Y combined with the different types of ligands in two groups of patients\: with neuroendocrine tumours and with non\-Hodgkin lymphomas, as well as the side effects of the treatment depending on the exposure of the critical organs. 32 patients \(19 females and 13 males \- 59,37% and 40,63% of the study subgroup respectively\) aged 37\-75 years \(mean age 58,03±10,75 years\) with histopathologically confirmed NET treated in Endocrinology Department of the University Hospital in Krakow between 2001 and 2007 were included in the study. 90,6% of patients were diagnosed with disseminated disease. In 3 patients the tumour was inoperable. Radioimmunotherapy was instituted in 30 patients \(16 females and 14 males \- 53,33% and 46,67% of the study subgroup respectively\) aged 41\-82 years \(mean age 58,73 ± 11,26 years\) diagnosed with non\-Hodgkin lymphoma CD20\+ of III and IV stage according to Ann Arbor classification. All patients were followed\-up by the Haematology Department of the University Hospital in Krakow. The isotope therapy \(1\) was the first line of the treatment, \(2\) was initiated af"]

Number of results: 1